A seasoned administrator and President and CEO of Sogealpha Inc., Jean-Pierre Robert is an internationally recognized ambassador of medical innovations and a well-known leader in the pharmaceutical and medical device fields.
The content of this site is reserved for healthcare professionals, in accordance with Law No. 2011-2012 of December 29, 2011 relating to strengthening the health safety of medicines and health products, including the implementing decree relating to the advertising.
By clicking on OK, you confirm that you are a healthcare professional.
In 2009, two physician-researchers, Dr. Erwan L’Her (head of the intensive care unit and INSERM researcher at the University Hospital of Brest) and Dr. François Lellouche (intensivist and researcher at the QHLI) joined forces after a clinical research project to develop a device to automate the administration of oxygen therapy. They founded OxyNov Inc to focus entirely on developing the FreeO2 device, thus improving the application of this treatment on a daily basis.
Our mission is to overcome the current limitations of respiratory care and change clinical practice to improve the safety and quality of life of patients and optimize care in a context of an increasing number of patients and of hospitalization cost control. We are and will remain pioneers in oxygen therapy.
Provide powerful, innovative, and cutting-edge technology to advance oxygen therapy by preventing hyperoxia and hypoxemia and significantly improving cardiopulmonary monitoring in patients.
Work with integrity by actively listening to patients and healthcare professionals and creating a culture of innovation that allows us to remain pioneers in reimagined, improved oxygen therapy.
Patrice Allibert has 35 years of experience in the medical devices and animal health fields. He is responsible for launching a number of platforms and tests, all CE-IVD certified, FDA cleared, or USDA cleared . He is the former CEO of GenePOC and Vice President of R&D and Innovation of BD. His current and recent board experience includes ImmunExpress, FOLIA BioTech, and the Canadian Institute of Health Research.
Dr. Lellouche is the co-inventor of FreeO2 and an intensivist and researcher specializing in the respiratory field at the Quebec Heart and Lung Institute. His areas of research include the automation of oxygen therapy and mechanical ventilation, innovation in respiratory support and monitoring, automated high-flow NIV devices, and respiratory humidification.
Dr. L’Her is the co-inventor of FreeO2, an intensive care pulmonologist, an INSERM researcher specializing in the respiratory field, and head of intensive care medicine and reanimation at the Brest University Hospital. He is also the chief national scientist of the IDEFI (Initiatives d’excellence en formations innovantes) program in the REMIS network, head researcher at the INSERM’s LaTIM laboratory, and professor of research in pulmonology and the respiratory field.